Screener by Innerkore

Procter & Gamble Health Limited

NSE: PGHLBSE: 500126HealthcarePharmaceuticals & Biotechnology

Procter & Gamble Health Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: PGHL and BSE: 500126 (ISIN INE199A01012).

It has a market capitalisation of ₹8,503 crore, a last close of ₹5,136 on 2026-10-19, a one-year return of -17.8%.

Valuation: a price-to-earnings ratio of 23.83x, a dividend yield of 3.0%.

Profitability: an operating margin of 32.5%.

Growth: sales growth of 5.2% a year over three years, net profit growth of 15.9% a year over three years.

Balance sheet and ownership: promoter holding of 51.8%.

Key figures for PGHL, prices as of 2026-10-19
MetricValue
Market capitalisation8,503
Last close₹5,136
P/E (TTM)23.83x
Dividend yield3.0%
Operating margin (TTM)32.5%
Sales growth, 3-year CAGR5.2%
Profit growth, 3-year CAGR15.9%
Promoter holding51.8%
1-year return-17.8%

Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means